Cargando…

Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands: A test-negative case-control study

INTRODUCTION: Real-world vaccine effectiveness (VE) estimates are essential to identify potential groups at higher risk of break-through infections and to guide policy. We assessed the VE of COVID-19 vaccination against COVID-19 hospitalization, while adjusting and stratifying for patient characteri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niessen, F.A., Knol, M.J., Hahné, S.J.M., Bonten, M.J.M., Bruijning-Verhagen, P.C.J.L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174354/ https://www.ncbi.nlm.nih.gov/pubmed/35863935 http://dx.doi.org/10.1016/j.vaccine.2022.06.011

Ejemplares similares

Acute Gastroenteritis Disease Burden in Infants With Medical Risk Conditions in the Netherlands
por: van Dongen, Josephine A. P., et al.
Publicado: (2020)

Baseline incidence of intussusception in early childhood before rotavirus vaccine introduction, the Netherlands, January 2008 to December 2012
por: Gadroen, Kartini, et al.
Publicado: (2017)

Effect of vaccination on severity and infectiousness of measles during an outbreak in the Netherlands, 2013–2014
por: van Dam, A.S.G., et al.
Publicado: (2020)

Protection against invasive meningococcal disease and vaccination policy in the Netherlands
por: Ohm, M, et al.
Publicado: (2022)

Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Delta and Omicron Infection and Infectiousness Within Households in the Netherlands Between July 2021 and August 2022
por: Hoeve, Christina E, et al.
Publicado: (2023)

Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study
por: Ohm, Milou, et al.
Publicado: (2021)

Extended-spectrum beta-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli isolates causing bacteremia in the Netherlands (2014 – 2016) differ in clonal distribution, antimicrobial resistance gene and virulence gene content
por: van Hout, Denise, et al.
Publicado: (2020)

Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022
por: Huiberts, Anne J, et al.
Publicado: (2023)

Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination
por: Bruijning-Verhagen, Patricia, et al.
Publicado: (2013)

Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands
por: Hoes, Joske, et al.
Publicado: (2018)

Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from July 12, 2021 to June 6, 2022: A prospective cohort study
por: Huiberts, Anne J., et al.
Publicado: (2023)

Number of COVID-19 hospitalisations averted by vaccination: Estimates for the Netherlands, January 6, 2021 through August 30, 2022
por: van Iersel, Senna C.J.L., et al.
Publicado: (2023)

Determinants of Rotavirus Transmission: A Lag Nonlinear Time Series Analysis
por: van Gaalen, Rolina D., et al.
Publicado: (2017)

Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands
por: Tielemans, Susanne M A J, et al.
Publicado: (2017)

Sex differences in COVID-19 mortality in the Netherlands
por: Niessen, Annabel, et al.
Publicado: (2022)

COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021
por: van Ewijk, Catharina E, et al.
Publicado: (2022)

Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands
por: Mangen, Marie-Josée J., et al.
Publicado: (2015)

Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022
por: de Gier, Brechje, et al.
Publicado: (2023)

COVID-19 outbreak in an elderly care home: Very low vaccine effectiveness and late impact of booster vaccination campaign
por: van Ewijk, Catharina E., et al.
Publicado: (2022)

Neighbourhood sociodemographic factors and COVID-19 vaccine uptake in the Netherlands: an ecological analysis
por: Labuschagne, Lisanne J. E., et al.
Publicado: (2023)

The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly: Exploratory analysis of the CAPiTA trial
por: Huijts, S.M., et al.
Publicado: (2018)

Sex differences in invasive pneumococcal disease and the impact of pneumococcal conjugate vaccination in the Netherlands, 2004 to 2015
por: Wagenvoort, Gertjan H J, et al.
Publicado: (2017)

Epidemiologic trends for isolated tibia shaft fracture admissions in The Netherlands between 1991 and 2012
por: Leliveld, Mandala S., et al.
Publicado: (2019)

Determinants of COVID-19 vaccine uptake in the Netherlands: A nationwide registry-based study
por: Pijpers, J, et al.
Publicado: (2023)

Heat and emergency room admissions in the Netherlands
por: van Loenhout, Joris Adriaan Frank, et al.
Publicado: (2018)

Design of the PROUD study: PCR faeces testing in outpatients with diarrhoea
por: Schierenberg, Alwin, et al.
Publicado: (2016)

Out-of-season increase of puerperal fever with group A Streptococcus infection: a case–control study, Netherlands, July to August 2018
por: van den Boogaard, Jossy, et al.
Publicado: (2020)

Tolerability of Early Measles-Mumps-Rubella Vaccination in Infants Aged 6–14 Months During a Measles Outbreak in The Netherlands in 2013–2014
por: van der Maas, Nicoline A. T., et al.
Publicado: (2016)

Epidemic of Mumps among Vaccinated Persons, the Netherlands, 2009–2012
por: Sane, Jussi, et al.
Publicado: (2014)

Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands
por: Knol, Mirjam J., et al.
Publicado: (2015)

Model-based evaluation of school- and non-school-related measures to control the COVID-19 pandemic
por: Rozhnova, Ganna, et al.
Publicado: (2021)

Measles Outbreak, the Netherlands, 2008
por: Hahné, Susan, et al.
Publicado: (2010)

Trends in incidence, health care consumption, and costs for proximal femoral fractures in the Netherlands between 2000 and 2019: a nationwide study
por: Zeelenberg, M.L., et al.
Publicado: (2023)

Role of cellular immune factors in coronavirus A59 induced demyelination
por: Koolen, M.J.M., et al.
Publicado: (1988)

Response to Letter to the Editor: Importance of considering high-risk behaviours in COVID-19 vaccine effectiveness estimates with observational studies
por: van Ewijk, Catharina E, et al.
Publicado: (2023)

Psychometric Validation of a General Health Quality of Life Tool for Cats Used to Compare Healthy Cats and Cats with Chronic Kidney Disease
por: Bijsmans, E.S., et al.
Publicado: (2016)

Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials
por: ten Doesschate, Thijs, et al.
Publicado: (2020)

Correction to: Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials
por: ten Doesschate, Thijs, et al.
Publicado: (2020)

Admission testing for higher education: A multi-cohort study on the validity of high-fidelity curriculum-sampling tests
por: Niessen, A. Susan M., et al.
Publicado: (2018)

Evaluation and Diagnostic Potential of Serum Ghrelin in Feline Hypersomatotropism and Diabetes Mellitus
por: Jensen, K.B., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rashfnn8mlt4q2tenspnqjjv1h